Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant

References

• Willmot F, Robertson G. Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet 1920;2:848–849.
   Google Scholar
• McFarlane AL, Branday WJ. Enlarged liver with ascites in children. Br Med J 1945;1:838–840.
   PubMed Web of Science ®Google Scholar
• Bras G, Hill KR. Veno-occlusive disease of the liver; essential pathology. Lancet 1956;271:161–163.
   PubMed Web of Science ®Google Scholar
• McDonald GB, Hinds MS, Fisher LD, . Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:255–267.
   PubMed Web of Science ®Google Scholar
• Dulley FL, Kanfer EJ, Appelbaum FR, . Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987;43:870–873.
   PubMed Web of Science ®Google Scholar
• DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27–42.
   PubMed Web of Science ®Google Scholar
• Jagt CT, Zuckermann M, Ten Kate F, . Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: a clinico-pathological analysis. Pediatr Blood Cancer 2009;53:1211–1215.
   PubMed Web of Science ®Google Scholar
• Nakazawa Y, Chisuwa H, Mita A, . Life-threatening veno-occlusive disease after living-related liver transplantation. Transplantation 2003;75:727–730.
   PubMed Web of Science ®Google Scholar
• McKoy JM, Angelotta C, Bennett CL, . Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res 2007;31:599–604.
   PubMed Web of Science ®Google Scholar
• Coppell JA, Richardson PG, Soiffer R, . Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010;16:157–168.
   PubMed Web of Science ®Google Scholar
• Carreras E, Bertz H, Arcese W, . Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998;92: 3599–3604.
   PubMed Web of Science ®Google Scholar
• Jones RJ, Lee KS, Beschorner WE, . Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778–783.
   PubMed Web of Science ®Google Scholar
• Reiss U, Cowan M, McMillan A, . Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002;24:746–750.
   PubMed Web of Science ®Google Scholar
• Carreras E, Rosinol L, Terol MJ, . Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Biol Blood Marrow Transplant 2007;13: 1448–1454.
   PubMed Web of Science ®Google Scholar
• Meresse V, Hartmann O, Vassal G, . Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation:a study in 136 children. Bone Marrow Transplant 1992;10:135–141.
   PubMed Web of Science ®Google Scholar
• Dix SP, Wingard JR, Mullins RE, . Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant 1996;17:225–230.
   PubMed Web of Science ®Google Scholar
• Grochow LB, Jones RJ, Brundrett RB, . Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989;25:55–61.
   PubMed Web of Science ®Google Scholar
• Girinsky T, Benhamou E, Bourhis JH, . Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol 2000;18:981–986.
   PubMed Web of Science ®Google Scholar
• Toh HC, McAfee SL, Sackstein R, . Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 1999;24:891–895.
   PubMed Web of Science ®Google Scholar
• Shah MS, Jeevangi NK, Joshi A, . Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide. J Cancer Res Ther 2009;5: 312–314.
   PubMed Web of Science ®Google Scholar
• Platzbecker U, von Bonin M, Goekkurt E, . Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant 2009;15:101–108.
   PubMed Web of Science ®Google Scholar
• O'Donnell PH, Artz AS, Undevia SD, . Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. Leuk Lymphoma 2010;51:2240–2249.
   PubMed Web of Science ®Google Scholar
• Lee JL, Gooley T, Bensinger W, . Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 1999;5:306–315.
   PubMedGoogle Scholar
• Cantoni N, Gerull S, Heim D, . Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplant 2011;46:344–349.
   PubMed Web of Science ®Google Scholar
• Carreras E, Diaz-Beya M, Rosinol L, . The incidence of veno-occlusive disease following allogeneic hematopoietic cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 2011;17:1713–1720.
   PubMed Web of Science ®Google Scholar
• Sakaguchi H, Watanabe N, Muramatsu H, . Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy. Pediatr Blood Cancer 2010;55:1118–1125.
   PubMed Web of Science ®Google Scholar